Company Encyclopedia
View More
name
ASK PHARM
002755.SZ
Beijing Aosaikang Pharmaceutical Co., Ltd. researches, develops, manufactures, markets, and sells pharmaceuticals, fine chemicals, and health-care products in China. It offers proton pump inhibitor injections and oncology medicines, as well as APIs. The company provides its products in oncology, antibiotic, and other areas.
3.159 T
002755.SZMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
B
PharmaceuticalsIndustry
Industry Ranking20/223
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreB
    • ROE8.29%B
    • Profit Margin14.04%B
    • Gross Margin75.46%A
  • Growth ScoreB
    • Revenue YoY6.96%C
    • Net Profit YoY57.28%B
    • Total Assets YoY12.16%B
    • Net Assets YoY4.66%C
  • Cash ScoreC
    • Cash Flow Margin712.06%B
    • OCF YoY6.96%C
  • Operating ScoreC
    • Turnover0.44C
  • Debt ScoreB
    • Gearing Ratio26.25%B

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    ASK PHARM released its performance for the first three quarters, with a net profit attributable to the parent company of 223 million yuan, a year-on-year increase of 75.81%

    According to the Zhitong Finance APP, ASK PHARM released its third-quarter report for 2025. In the first three quarters, the company achieved operating revenue of 1.434 billion yuan, a year-on-year increase of 3.57%. The net profit attributable to shareholders of the listed company was 223 million yuan, a year-on-year increase of 75.81%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 186 million yuan, a year-on-year increase of 81.89%

    Zhitong·
    SZ
    300361
    0.00%
    SZ
    002755
    +0.29%
    Zhitong·
    SZ
    300361
    0.00%
    SZ
    002755
    +0.29%

    Aosaikang: Innovative drug ASKB589 will announce clinical research data at the 2025 ESMO Annual Meeting

    ASK PHARM announced that its subsidiary ASKGENE LIMITED will present clinical research data for the biopharmaceutical ASKB589 at the 2025 ESMO Annual Meeting. The drug, in combination with CAPOX and PD-1 inhibitors, has shown deep and lasting tumor remission and disease control in first-line treatment of advanced gastric cancer, with clear survival benefits. These positive clinical data will enhance the market competitiveness of the company's products

    Zhitong·
    SZ
    300361
    0.00%
    SZ
    002755
    +0.29%
    Zhitong·
    SZ
    300361
    0.00%
    SZ
    002755
    +0.29%

    Aosaikang's subsidiary signs ASKG712 project licensing agreement

    Aosaikang's holding subsidiary AskGene Pharma has signed a licensing agreement with Visara, allowing Visara to use the independently developed innovative drug ASKG712 in specific regions. This drug targets VEGF and ANG-2 and is currently undergoing Phase IIa clinical trials in China, showing good safety and efficacy. This collaboration will promote the research and commercialization of ASKG712, aligning with the company's strategic direction and is expected to have a positive impact on future performance

    Zhitong·
    SZ
    002755
    +0.29%
    SZ
    300361
    0.00%
    Zhitong·
    SZ
    002755
    +0.29%
    SZ
    300361
    0.00%

    The pharmaceutical sector fell at the beginning of trading, with SUNFLOWER dropping 10%

    The pharmaceutical sector fell at the beginning of trading, with SUNFLOWER dropping 10%, ASK PHARM falling over 7%, and multiple stocks including Staidson BioPharm, Hengrui Pharma, and EASTON BIOPHARMACEUTICALS declining

    Zhitong·
    SZ
    300204
    +1.32%
    SH
    600276
    +0.60%
    SH
    688513
    +0.09%
    Zhitong·
    SZ
    300204
    +1.32%
    SH
    600276
    +0.60%
    SH
    688513
    +0.09%

    The pharmaceutical sector fluctuates and strengthens, ASK PHARM hits the limit up

    The pharmaceutical sector fluctuated and strengthened, with ASK PHARM hitting the limit up, SUNFLOWER rising over 13%, and Cosunter, Xinlitai, Lummy, and INNOCARE among the top gainers

    Zhitong·
    SZ
    002755
    +0.29%
    SZ
    300111
    +0.69%
    SZ
    300436
    +0.09%
    Zhitong·
    SZ
    002755
    +0.29%
    SZ
    300111
    +0.69%
    SZ
    300436
    +0.09%
    © 2025 Longbridge｜Disclaimer